Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by South Dakota Investment Council

South Dakota Investment Council increased its holdings in Amedisys, Inc. (NASDAQ:AMED) by 5.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 50,841 shares of the health services provider’s stock after acquiring an additional 2,500 shares during the quarter. South Dakota Investment Council owned approximately 0.16% of Amedisys worth $4,616,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. Blue Trust Inc. raised its stake in Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after buying an additional 124 shares in the last quarter. HBW Advisory Services LLC acquired a new stake in Amedisys during the fourth quarter valued at approximately $38,000. Versant Capital Management Inc raised its position in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock worth $41,000 after purchasing an additional 183 shares during the period. KBC Group NV acquired a new stake in shares of Amedisys during the 3rd quarter worth approximately $63,000. Finally, Venturi Wealth Management LLC raised its position in shares of Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider’s stock worth $89,000 after purchasing an additional 779 shares during the period. Institutional investors and hedge funds own 94.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Stephens reiterated an “equal weight” rating and set a $101.00 price target on shares of Amedisys in a research report on Wednesday, February 12th. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $100.75.

Amedisys Stock Performance

Shares of AMED stock opened at $90.43 on Monday. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The firm has a market capitalization of $2.96 billion, a price-to-earnings ratio of 35.88, a price-to-earnings-growth ratio of 1.80 and a beta of 0.73. The business has a 50 day simple moving average of $90.74 and a 200 day simple moving average of $93.37. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.